menu
    • menu

    Company profile for TrialSpark

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TrialSpark is a technology company that helps bring treatments to patients faster. Today, clinical trials are the bottleneck to bringing life-saving treatments to patients. Trials are slow, inefficient, and expensive. We believe that we can use technology to accelerate the pace of clinical trials and bridge the gap between medical research and patients who need treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TrialSparkUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16 E 34th Street, Fl 10, New York, NY 10016, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.trialspark.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/trialspark/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TrialSpark Rebrands as Formation Bio
    TrialSpark Rebrands as Formation Bio

    05 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/trialspark-rebrands-as-formation-bio-continuing-its-commitment-to-advancing-drug-development-innovation-302006328.html

    PR NEWSWIRE
    05 Dec 2023
    Share Share
    TrialSpark doses first patient in Phase II trial of AD therapy
    TrialSpark doses first patient in Phase II trial of AD therapy

    24 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/trialspark-first-ad-therapy/

    CLINICAL TRIALS ARENA
    24 May 2023
    Share Share
    TrialSpark Announces First Patient Dosed in Phase 2 Trial for ASN008-201
    TrialSpark Announces First Patient Dosed in Phase 2 Trial for ASN008-201

    23 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/trialspark-announces-first-patient-dosed-in-phase-2-clinical-trial-for-asn008-201-in-atopic-dermatitis-301832396.html

    PR NEWSWIRE
    23 May 2023
    Share Share
    Sanofi inks deal with TrialSpark to find new drugs to acquire
    Sanofi inks deal with TrialSpark to find new drugs to acquire

    07 Oct 2022

    // Joseph Keenan FIERCEBIOTECH

    https://www.fiercebiotech.com/cro/sanofi-inks-partnership-deal-trialspark-help-identify-new-drugs

    Joseph Keenan FIERCEBIOTECH
    07 Oct 2022
    Share Share
    Paul Hudson & TrialSpark's desire to speed up development in 3 year, 6 drug goal
    Paul Hudson & TrialSpark's desire to speed up development in 3 year, 6 drug goal

    04 Oct 2022

    // Kyle LaHucik ENDPTS

    https://endpts.com/paul-hudson-and-trialsparks-mutual-desire-to-speed-up-development-converges-in-three-year-six-drug-goal/

    Kyle LaHucik ENDPTS
    04 Oct 2022
    Share Share
    TrialSpark licenses sprifermin from Merck KGaA; formation of High Line Bio
    TrialSpark licenses sprifermin from Merck KGaA; formation of High Line Bio

    10 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/trialspark-licenses-sprifermin-an-investigational-first-in-class-disease-modifying-treatment-for-osteoarthritis-from-merck-kgaa-darmstadt-germany-and-announces-formation-of-high-line-bio-301456562.html

    PRNEWSWIRE
    10 Jan 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search